Natalia Trufanova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Natalia Trufanova has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
- Oleh Trufanov
Institute for Problems of Cryobiology and Cryomedicine of the National Academy of Sciences of Ukraine, 61016 Kharkiv, Ukraine
8 shared publications Oleksandr Petrenko
Institute for Problems of Cryobiology and Cryomedicine National Academy of Sciences of Ukraine
8 shared publications- Daria V. Cherkashina
Institute for Problems of Cryobiology and Cryomedicine of NAS of Ukraine, 61016 Kharkiv, Ukraine
4 shared publications - Olena Revenko
Institute for Problems of Cryobiology and Cryomedicine of the National Academy of Sciences of Ukraine
4 shared publications - Alexander Yu. Petrenko
Institute for Problems of Cryobiology and Cryomedicine, National Academy of Sciences of Ukraine, Kharkiv, Ukraine
3 shared publications - Galyna Bozhok
Institute for Problems of Cryobiology and Cryomedicine, National Academy of Sciences of Ukraine, Kharkiv, Ukraine
3 shared publications
Latest Publications
- Open Access
- 31 March 2026
- Published by Private Company Technology Center in ScienceRise: Biological Science
- No. 1 (45),p. 19-29
Effect of gelatin on the properties of mesenchymal stromal cells during cultivation and hypothermic storage within core–shell alginate capsules
Mesenchymal stromal cells (MSCs) are widely used in regenerative medicine and cell engineering; however, conventional two-dimensional culture systems fail to reproduce the physiological microenvironment of cells and limit the preservation of their functional state. Objective. This study aimed to investigate the effect of gelatin concentration in the core of alginate core–shell capsules on the viability, metabolic activity and spatial organisation of human bone marrow-derived MSCs. Materials and Methods. Alginate core–shell capsules were fabricated using coaxial electrospraying with an alginate shell and hydrogel core containing different gelatin concentrations (0, 2.5, 5 and 7.5% w/v). Rheological properties of the core and shell materials were analysed by rotational rheometry. Cell viability was assessed using Live/Dead fluorescence staining, metabolic activity by Alamar Blue assay, and spatial organisation by light and fluorescence microscopy. Capsules were cultured under physiological conditions for 17 days and subsequently transferred to ambient temperature storage. Results. All capsule formulations supported high MSC viability during long-term culture. However, the functional state of the cells strongly depended on the core composition. Capsules containing 2.5% gelatin demonstrated the most pronounced increase in metabolic activity and the formation of interconnected, network-like cellular structures. Increasing gelatin concentration to 5–7.5% resulted in reduced metabolic activity and the formation of compact cell aggregates. Following storage at ambient temperature (22 °C), metabolic activity decreased in all groups, whereas cell viability remained stable. Conclusions. Gelatin concentration within the capsule core is a key parameter regulating MSC functional behaviour in three-dimensional culture systems. Alginate core–shell capsules represent a promising platform for short-term storage and transportation of cells while maintaining their viability and structural organisation
- 31 March 2026
- Published by Private Company Technology Center in ScienceRise: Biological Science
- No. 1 (45),p. 19-29
Open AccessEffect of gelatin on the properties of mesenchymal stromal cells during cultivation and hypothermic storage within core–shell alginate capsules
Mesenchymal stromal cells (MSCs) are widely used in regenerative medicine and cell engineering; however, conventional two-dimensional culture systems fail to reproduce the physiological microenvironment of cells and limit the preservation of their functional state. Objective. This study aimed to investigate the effect of gelatin concentration in the core of alginate core–shell capsules on the viability, metabolic activity and spatial organisation of human bone marrow-derived MSCs. Materials and Methods. Alginate core–shell capsules were fabricated using coaxial electrospraying with an alginate shell and hydrogel core containing different gelatin concentrations (0, 2.5, 5 and 7.5% w/v). Rheological properties of the core and shell materials were analysed by rotational rheometry. Cell viability was assessed using Live/Dead fluorescence staining, metabolic activity by Alamar Blue assay, and spatial organisation by light and fluorescence microscopy. Capsules were cultured under physiological conditions for 17 days and subsequently transferred to ambient temperature storage. Results. All capsule formulations supported high MSC viability during long-term culture. However, the functional state of the cells strongly depended on the core composition. Capsules containing 2.5% gelatin demonstrated the most pronounced increase in metabolic activity and the formation of interconnected, network-like cellular structures. Increasing gelatin concentration to 5–7.5% resulted in reduced metabolic activity and the formation of compact cell aggregates. Following storage at ambient temperature (22 °C), metabolic activity decreased in all groups, whereas cell viability remained stable. Conclusions. Gelatin concentration within the capsule core is a key parameter regulating MSC functional behaviour in three-dimensional culture systems. Alginate core–shell capsules represent a promising platform for short-term storage and transportation of cells while maintaining their viability and structural organisation
- Open Access
- 1 January 2026
- Published by Ivan Franko National University of Lviv
- p. 71-73
BIFIDOBACTERIUM BIFIDUM LVA-3 FERMENTATE AS AN ANTIBACTERIAL AND PRECONDITIONING AGENT FOR MESENCHYMAL STEM CELLS
The therapeutic efficacy of adipose tissue-derived mesenchymal stem cells (AD-MSCs) can be compromised by local inflammation and microbial infections at wound sites. Preconditioning MSCs with probiotic postbiotics offers a dual strategy to prime stem cell function and provide local antibacterial protection. This study evaluated the dose-dependent effects of heat-inactivated and sterile-filtered Bifidobacterium bifidum LVA-3 culture fermentate on its direct antagonistic activity against opportunistic pathogens and AD-MSC functional performance. At concentrations of 5–10 %, the fermentate effectively inhibited S. aureus, E. coli, and P. aeruginosa while maintaining AD-MSC adhesion, boosting metabolic activity, accelerating directional migration, and modulating lineage-specific differentiation. Preconditioning AD-MSCs with B. bifidum LVA-3 fermentate represents a novel biotechnological approach for optimizing cell-based therapies targeting infected and impaired tissue wounds. Keywords: Bifidobacterium bifidum fermentate, mesenchymal stem cells, postbiotics, preconditioning, tissue regeneration.
- 1 January 2026
- Published by Ivan Franko National University of Lviv
- p. 71-73
Open AccessBIFIDOBACTERIUM BIFIDUM LVA-3 FERMENTATE AS AN ANTIBACTERIAL AND PRECONDITIONING AGENT FOR MESENCHYMAL STEM CELLS
The therapeutic efficacy of adipose tissue-derived mesenchymal stem cells (AD-MSCs) can be compromised by local inflammation and microbial infections at wound sites. Preconditioning MSCs with probiotic postbiotics offers a dual strategy to prime stem cell function and provide local antibacterial protection. This study evaluated the dose-dependent effects of heat-inactivated and sterile-filtered Bifidobacterium bifidum LVA-3 culture fermentate on its direct antagonistic activity against opportunistic pathogens and AD-MSC functional performance. At concentrations of 5–10 %, the fermentate effectively inhibited S. aureus, E. coli, and P. aeruginosa while maintaining AD-MSC adhesion, boosting metabolic activity, accelerating directional migration, and modulating lineage-specific differentiation. Preconditioning AD-MSCs with B. bifidum LVA-3 fermentate represents a novel biotechnological approach for optimizing cell-based therapies targeting infected and impaired tissue wounds. Keywords: Bifidobacterium bifidum fermentate, mesenchymal stem cells, postbiotics, preconditioning, tissue regeneration.
- 26 December 2025
- Published by V. N. Karazin Kharkiv National University in The Journal of V.N.Karazin Kharkiv National University. Series "Biology"
- p. 52
Bioengineering of probiotic-loaded hydrogel films with high antimicrobial activity
The rise of antimicrobial resistance complicates the management of infected wounds, necessitating novel therapeutic strategies. Probiotic-based therapies offer a promising alternative, but their efficacy depends on delivering a high concentration of viable, active microorganisms to the wound site. Alginate hydrogels are excellent carriers, but freshly prepared probiotic-loaded films often lack immediate therapeutic activity. This study aimed to investigate the effect of a post-immobilization cultivation period on the viability and antagonistic activity of Bifidobacterium bifidum LVA-3 and Lactobacillus bulgaricus 1Z 03501 immobilized in calcium alginate films. The central hypothesis was that this cultivation step would function as an in-situ bio-activation process, enhancing the films' therapeutic potential. Methods. B. bifidum LVA-3 and L. bulgaricus 1Z 03501 were immobilized in calcium alginate films. The films were then cultivated in a nutrient medium for 2, 4, or 6 days at 37 °C. Viable cell counts were determined by plate counting after film dissolution. Antagonistic activity was assessed using an agar overlay diffusion method against pathogenic test strains (Staphylococcus aureus 209, Pseudomonas aeruginosa 9027, and Escherichia coli B), measuring the diameter of inhibition zones. The experimental data revealed that uncultivated films (Day 0) showed no antagonistic activity. Post-immobilization cultivation led to a significant increase in viable cell counts for both strains, with populations rising by over 100- to 500-fold within 2 days to therapeutically relevant levels (>10¹⁰ CFU/mL). B. bifidum LVA-3 showed rapid growth peaking at day 2, while L. bulgaricus 1Z 03501 maintained a high, stable population through day 6. This increased cell density directly correlated with the emergence of potent antagonistic activity against all three pathogenic strains. In summary, it can be concluded that a post-immobilization cultivation step is a critical bio-activation process that transforms probiotic-loaded alginate films from passive carriers into functionally potent biomaterials. This strategy effectively increases probiotic viability to therapeutic concentrations and enables the in-situ production of antimicrobial compounds. This two-step approach of immobilization followed by cultivation presents a novel method for developing high-efficacy probiotic formulations for applications such as bioactive wound dressings.
- 26 December 2025
- Published by V. N. Karazin Kharkiv National University in The Journal of V.N.Karazin Kharkiv National University. Series "Biology"
- p. 52
Bioengineering of probiotic-loaded hydrogel films with high antimicrobial activity
The rise of antimicrobial resistance complicates the management of infected wounds, necessitating novel therapeutic strategies. Probiotic-based therapies offer a promising alternative, but their efficacy depends on delivering a high concentration of viable, active microorganisms to the wound site. Alginate hydrogels are excellent carriers, but freshly prepared probiotic-loaded films often lack immediate therapeutic activity. This study aimed to investigate the effect of a post-immobilization cultivation period on the viability and antagonistic activity of Bifidobacterium bifidum LVA-3 and Lactobacillus bulgaricus 1Z 03501 immobilized in calcium alginate films. The central hypothesis was that this cultivation step would function as an in-situ bio-activation process, enhancing the films' therapeutic potential. Methods. B. bifidum LVA-3 and L. bulgaricus 1Z 03501 were immobilized in calcium alginate films. The films were then cultivated in a nutrient medium for 2, 4, or 6 days at 37 °C. Viable cell counts were determined by plate counting after film dissolution. Antagonistic activity was assessed using an agar overlay diffusion method against pathogenic test strains (Staphylococcus aureus 209, Pseudomonas aeruginosa 9027, and Escherichia coli B), measuring the diameter of inhibition zones. The experimental data revealed that uncultivated films (Day 0) showed no antagonistic activity. Post-immobilization cultivation led to a significant increase in viable cell counts for both strains, with populations rising by over 100- to 500-fold within 2 days to therapeutically relevant levels (>10¹⁰ CFU/mL). B. bifidum LVA-3 showed rapid growth peaking at day 2, while L. bulgaricus 1Z 03501 maintained a high, stable population through day 6. This increased cell density directly correlated with the emergence of potent antagonistic activity against all three pathogenic strains. In summary, it can be concluded that a post-immobilization cultivation step is a critical bio-activation process that transforms probiotic-loaded alginate films from passive carriers into functionally potent biomaterials. This strategy effectively increases probiotic viability to therapeutic concentrations and enables the in-situ production of antimicrobial compounds. This two-step approach of immobilization followed by cultivation presents a novel method for developing high-efficacy probiotic formulations for applications such as bioactive wound dressings.
- 1 October 2025
- Published by SAGE Publications in Biopreservation and Biobanking
- Vol. 23 (5) , 431-438
Metabolic Mode of Alginate-Encapsulated Human Mesenchymal Stromal Cells as a Background for Storage at Ambient Temperature
Introduction: Human mesenchymal stromal cells (MSCs) are attractive for both medical practice and biomedical research. Nonfreezing short-term storage may provide safe and simple transportation and promote the practical use of MSCs. Objectives: We aimed to determine the duration of efficient storage at ambient temperature (22°C) of human dermal MSCs in different three-dimensional organization and to investigate the role of cell metabolic mode in the resistance to the ambient storage damaging factors. Methods: MSCs in monolayer, suspension, and encapsulated in alginate microspheres (AMS) were stored in sealed containers at 22°С in culture medium. Viability (fluorescein diacetate /ethidium bromide) and metabolic activity (Alamar Blue assay) were assessed at 0, 3, 7, 10, and 14 days of the storage. Mitochondrial membrane potential (JC-1 test), cell cycle analysis, reactive oxygen species level, and resistance to hydrogen peroxide were analyzed under culture conditions. Results: Alginate encapsulation was shown to maintain viability (about 85%), metabolic activity, and adhesion ability during storage for 7 days. The storage of MSCs in both monolayer and suspension was less efficient. Culture of MSCs in AMS decreased basal metabolic activity, mitochondrial activity, and led to reversible cell cycle arrest compared to standard two-dimensional culture. MSCs in AMS have a lower basal level of reactive oxygen species and higher resistance to hydrogen peroxide compared with those in monolayer culture. Conclusion: Revealed shift into quiescent metabolic mode is essential for alginate-encapsulated MSCs resistance to storage at ambient temperature.
- 1 October 2025
- Published by SAGE Publications in Biopreservation and Biobanking
- Vol. 23 (5) , 431-438
Metabolic Mode of Alginate-Encapsulated Human Mesenchymal Stromal Cells as a Background for Storage at Ambient Temperature
Introduction: Human mesenchymal stromal cells (MSCs) are attractive for both medical practice and biomedical research. Nonfreezing short-term storage may provide safe and simple transportation and promote the practical use of MSCs. Objectives: We aimed to determine the duration of efficient storage at ambient temperature (22°C) of human dermal MSCs in different three-dimensional organization and to investigate the role of cell metabolic mode in the resistance to the ambient storage damaging factors. Methods: MSCs in monolayer, suspension, and encapsulated in alginate microspheres (AMS) were stored in sealed containers at 22°С in culture medium. Viability (fluorescein diacetate /ethidium bromide) and metabolic activity (Alamar Blue assay) were assessed at 0, 3, 7, 10, and 14 days of the storage. Mitochondrial membrane potential (JC-1 test), cell cycle analysis, reactive oxygen species level, and resistance to hydrogen peroxide were analyzed under culture conditions. Results: Alginate encapsulation was shown to maintain viability (about 85%), metabolic activity, and adhesion ability during storage for 7 days. The storage of MSCs in both monolayer and suspension was less efficient. Culture of MSCs in AMS decreased basal metabolic activity, mitochondrial activity, and led to reversible cell cycle arrest compared to standard two-dimensional culture. MSCs in AMS have a lower basal level of reactive oxygen species and higher resistance to hydrogen peroxide compared with those in monolayer culture. Conclusion: Revealed shift into quiescent metabolic mode is essential for alginate-encapsulated MSCs resistance to storage at ambient temperature.
- Open Access
Unlocking MSC Potential: Metabolic Reprogramming via Synthetic Biology Approaches
Metabolic engineering of mesenchymal stem/stromal cells (MSCs) represents a compelling frontier for advanced cellular therapies, enabling the precise tuning of their biological outputs. This feature paper examines the critical role of engineered culture microenvironments, specifically 3D platforms, hypoxic preconditioning, and other priming approaches, which are synthetic biology strategies used to guide and optimize MSC metabolic states for desired functional outcomes. We show that these non-genetic approaches can significantly enhance MSC survival, immunomodulatory capacity, and regenerative potential by shifting their metabolism toward a more glycolytic phenotype. Furthermore, we propose a new paradigm of “designer” MSCs, which are programmed with synthetic circuits to sense and respond to the physiological cues of an injured microenvironment. This approach promises to transform regenerative medicine from an inconsistent field into a precise, predictable, and highly effective therapeutic discipline.
Open AccessUnlocking MSC Potential: Metabolic Reprogramming via Synthetic Biology Approaches
Metabolic engineering of mesenchymal stem/stromal cells (MSCs) represents a compelling frontier for advanced cellular therapies, enabling the precise tuning of their biological outputs. This feature paper examines the critical role of engineered culture microenvironments, specifically 3D platforms, hypoxic preconditioning, and other priming approaches, which are synthetic biology strategies used to guide and optimize MSC metabolic states for desired functional outcomes. We show that these non-genetic approaches can significantly enhance MSC survival, immunomodulatory capacity, and regenerative potential by shifting their metabolism toward a more glycolytic phenotype. Furthermore, we propose a new paradigm of “designer” MSCs, which are programmed with synthetic circuits to sense and respond to the physiological cues of an injured microenvironment. This approach promises to transform regenerative medicine from an inconsistent field into a precise, predictable, and highly effective therapeutic discipline.
- Open Access
- 2 September 2025
- Published by MDPI AG in Preprints.org
Unlocking MSC Potential: Metabolic Reprogramming via Synthetic Biology Approaches
Metabolic engineering of mesenchymal stem/stromal cells (MSCs) represents a compelling frontier for advanced cellular therapies, enabling the precise tuning of their biological outputs. This feature paper examines the critical role of engineered culture microenvironments, specifically 3D platforms, hypoxic preconditioning, and other priming approaches, as synthetic biology strategies to guide and optimize MSC metabolic states for desired functional outcomes. We show that these non-genetic approaches significantly enhance MSC survival, immunomodulatory capacity, and regenerative potential by shifting their metabolism toward a more glycolytic phenotype. Furthermore, we propose a new paradigm of "designer" MSCs, which are programmed with synthetic circuits to sense and respond to the physiological cues of an injured microenvironment. This approach promises to transform regenerative medicine from an inconsistent field into a precise, predictable, and highly effective therapeutic discipline.
- 2 September 2025
- Published by MDPI AG in Preprints.org
Open AccessUnlocking MSC Potential: Metabolic Reprogramming via Synthetic Biology Approaches
Metabolic engineering of mesenchymal stem/stromal cells (MSCs) represents a compelling frontier for advanced cellular therapies, enabling the precise tuning of their biological outputs. This feature paper examines the critical role of engineered culture microenvironments, specifically 3D platforms, hypoxic preconditioning, and other priming approaches, as synthetic biology strategies to guide and optimize MSC metabolic states for desired functional outcomes. We show that these non-genetic approaches significantly enhance MSC survival, immunomodulatory capacity, and regenerative potential by shifting their metabolism toward a more glycolytic phenotype. Furthermore, we propose a new paradigm of "designer" MSCs, which are programmed with synthetic circuits to sense and respond to the physiological cues of an injured microenvironment. This approach promises to transform regenerative medicine from an inconsistent field into a precise, predictable, and highly effective therapeutic discipline.
- Open Access
- 30 August 2025
- Published by Private Company Technology Center in ScienceRise: Pharmaceutical Science
- No. 4 (56),p. 35-42
Dose-dependent effects of mitomycin С in non-healing wound modeling
Non-healing or chronic wounds are widely distributed complications of several pathologic states. A study of healing mechanisms requires an adequate animal model of such wounds. Use of rodents, one of the most available laboratory animals, is linked with some problems: wound edge contraction that precedes re-epithelialization. Mitomycin C (MMC), as a pharmacological inhibitor of cell proliferation, can be used in chronic wound modelling. The aim. The objective of the research was to create a model of non-healing (chronic) wound by surgically limiting its contraction and inhibiting recovery rate with the pharmaceutical agent mitomycin C (MMC). Materials and methods. Male Balb/c mice were used. Two layers of skin were pierced through, resulting in the simultaneous formation of two wounds (~0.6 cm3), whose edges were sutured surgically to hinder their contraction. Wounds were additionally treated with 0.5, 1, 2, and 3 mg/ml MMC. The delay of healing was assessed by measuring wound area and by morphological and histological examination. Results. The application of 2 and 3 mg/ml MMC for surgically fortified excision wounds resulted in a significantly increased area by day 21 and 28 compared with groups treated with lower doses. Also, wounds had loci of necrosis and infiltration. Delayed re-epithelialization and irregular collagen fibres were observed histologically after treatment with 2 and 3 mg/ml. Considering the absence of differences between wounds treated with 2 and 3 mg/ml MMC and its potential toxic effects, 2 mg/ml was recommended for non-healing wound modelling. Conclusions. An optimal model of non-healing (chronic) wound was created. The main aspects of the murine model can be outlined as follows: the use of surgical fixation of wound edges to a dense polymer base and treatment with 2 mg/ml MMC
- 30 August 2025
- Published by Private Company Technology Center in ScienceRise: Pharmaceutical Science
- No. 4 (56),p. 35-42
Open AccessDose-dependent effects of mitomycin С in non-healing wound modeling
Non-healing or chronic wounds are widely distributed complications of several pathologic states. A study of healing mechanisms requires an adequate animal model of such wounds. Use of rodents, one of the most available laboratory animals, is linked with some problems: wound edge contraction that precedes re-epithelialization. Mitomycin C (MMC), as a pharmacological inhibitor of cell proliferation, can be used in chronic wound modelling. The aim. The objective of the research was to create a model of non-healing (chronic) wound by surgically limiting its contraction and inhibiting recovery rate with the pharmaceutical agent mitomycin C (MMC). Materials and methods. Male Balb/c mice were used. Two layers of skin were pierced through, resulting in the simultaneous formation of two wounds (~0.6 cm3), whose edges were sutured surgically to hinder their contraction. Wounds were additionally treated with 0.5, 1, 2, and 3 mg/ml MMC. The delay of healing was assessed by measuring wound area and by morphological and histological examination. Results. The application of 2 and 3 mg/ml MMC for surgically fortified excision wounds resulted in a significantly increased area by day 21 and 28 compared with groups treated with lower doses. Also, wounds had loci of necrosis and infiltration. Delayed re-epithelialization and irregular collagen fibres were observed histologically after treatment with 2 and 3 mg/ml. Considering the absence of differences between wounds treated with 2 and 3 mg/ml MMC and its potential toxic effects, 2 mg/ml was recommended for non-healing wound modelling. Conclusions. An optimal model of non-healing (chronic) wound was created. The main aspects of the murine model can be outlined as follows: the use of surgical fixation of wound edges to a dense polymer base and treatment with 2 mg/ml MMC
- 30 June 2025
- Published by National Academy of Sciences of Ukraine (Co. LTD Ukrinformnauka) (Publications) in Problems of Cryobiology and Cryomedicine
- Vol. 35 (2) , 103-109
Cryopreservation of mesenchymal stem cells within macroporous matrices after sucrose pretreatment
Mesenchymal stromal/stem cells (MSCs) attract the attention of scientists and specialists in various fields of medicine due to their high immunomodulatory and regenerative potential, ability to multilineage differentiation. Effective storage technologies are essential for the implementation of MSCs into medical and laboratory practice. The article investigates the effect of pretreatment with sucrose on the viability, metabolic activity and differentiation potential of MSCs after cryopreservation in three-dimensional (3D) macroporous matrices. The results of the study showed that pretreatment with sucrose increased the efficiency of cell cryopreservation in collagen matrices by slow cooling in the presence of 10% DMSO and serum. The viability and metabolic activity of cells after cryopreservation in 3D matrices was significantly higher when treated with sucrose. It was also found that cells after cryopreservation retained the ability to proliferate and multilineage differentiation. The findings suggest that using sucrose for cell pretreatment is a promising approach to reduce cryodamage during their cryopreservation in 3D matrices and opens up new opportunities for increasing the efficiency of storage of tissue-engineered constructs.
- 30 June 2025
- Published by National Academy of Sciences of Ukraine (Co. LTD Ukrinformnauka) (Publications) in Problems of Cryobiology and Cryomedicine
- Vol. 35 (2) , 103-109
Cryopreservation of mesenchymal stem cells within macroporous matrices after sucrose pretreatment
Mesenchymal stromal/stem cells (MSCs) attract the attention of scientists and specialists in various fields of medicine due to their high immunomodulatory and regenerative potential, ability to multilineage differentiation. Effective storage technologies are essential for the implementation of MSCs into medical and laboratory practice. The article investigates the effect of pretreatment with sucrose on the viability, metabolic activity and differentiation potential of MSCs after cryopreservation in three-dimensional (3D) macroporous matrices. The results of the study showed that pretreatment with sucrose increased the efficiency of cell cryopreservation in collagen matrices by slow cooling in the presence of 10% DMSO and serum. The viability and metabolic activity of cells after cryopreservation in 3D matrices was significantly higher when treated with sucrose. It was also found that cells after cryopreservation retained the ability to proliferate and multilineage differentiation. The findings suggest that using sucrose for cell pretreatment is a promising approach to reduce cryodamage during their cryopreservation in 3D matrices and opens up new opportunities for increasing the efficiency of storage of tissue-engineered constructs.
- 30 May 2025
- Published by Institute of Cell Therapy in Cell and Organ Transplantology
- Vol. 14 (1)
Comprehensive characterization of human Wharton’s jelly mesenchymal stromal cells isolated by the combined explant-enzymatic method
Human mesenchymal stromal cells (MSCs) derived from Wharton’s jelly (WJ) are a premier source for regenerative medicine. However, standardized isolation protocols that ensure both high cell yield and maintained proliferative potential remain a subject of active research. This study is aimed to evaluate the efficiency of a combined explant-enzymatic method for human WJ-MSC isolation and characterize the resulting cell populations. Materials and methods. Cells were isolated using a combined explant-enzymatic method. Minced WJ fragments were cultured on gelatin-coated surfaces for 7 days, then explants underwent a brief (5–10 min) in situ enzymatic treatment with a trypsin-Versene solution, followed by further co-cultivation of the tissue fragments and released cells for an additional 7 days prior to the first passage. Cell characterization included colony-forming unit (CFU), immunophenotyping (CD29, CD90, CD73, CD105, CD34, CD45), directed differentiation (adipogenic and osteogenic), and secretory activity assays. Proliferative kinetics were assessed by calculating the population doubling time (PDT) across 5 passages. Secretory profile of WJ-MSCs (growth factors and cytokines regulating reparative-regenerative processes) was studied by enzyme-linked immunosorbent assay of conditioned media collected after 48 h cell incubation in minimal culture media. Results. The combined method ensured a stable cell yield with high reproducibility. Significant inter-donor variability in primary cell yield was noted. Isolated cells fulfilled the ISCT minimal criteria, exhibiting typical fibroblast-like morphology, characteristic immunophenotype, differentiation potential, and a high proportion of CFU, indicating the preservation of primitive progenitors. Proliferative analysis showed that PDT values remained comparable and did not change significantly between passages 1 and 3. Conditioned media from WJ-MSCs contained wide range of growth factors and cytokines, with inter-donor variability: VEGF, EGF, PDGF-BB, SCF, TNF-α, and TGF-β exhibited wide fluctuations, whereas NGF-β and FGF-β were relatively stable. Overall, WJ-MSC CM were characterized by very high levels of VEGF and EGF, high PDGF-BB, elevated TNF-α and TGF-β, and the lowest levels of FGF-β. Conclusions. The combined explant-enzymatic method is an efficient and standardized protocol for human WJ-MSC isolation, preserving high functional potency of cells for clinical and biobanking purposes.
- 30 May 2025
- Published by Institute of Cell Therapy in Cell and Organ Transplantology
- Vol. 14 (1)
Comprehensive characterization of human Wharton’s jelly mesenchymal stromal cells isolated by the combined explant-enzymatic method
Human mesenchymal stromal cells (MSCs) derived from Wharton’s jelly (WJ) are a premier source for regenerative medicine. However, standardized isolation protocols that ensure both high cell yield and maintained proliferative potential remain a subject of active research. This study is aimed to evaluate the efficiency of a combined explant-enzymatic method for human WJ-MSC isolation and characterize the resulting cell populations. Materials and methods. Cells were isolated using a combined explant-enzymatic method. Minced WJ fragments were cultured on gelatin-coated surfaces for 7 days, then explants underwent a brief (5–10 min) in situ enzymatic treatment with a trypsin-Versene solution, followed by further co-cultivation of the tissue fragments and released cells for an additional 7 days prior to the first passage. Cell characterization included colony-forming unit (CFU), immunophenotyping (CD29, CD90, CD73, CD105, CD34, CD45), directed differentiation (adipogenic and osteogenic), and secretory activity assays. Proliferative kinetics were assessed by calculating the population doubling time (PDT) across 5 passages. Secretory profile of WJ-MSCs (growth factors and cytokines regulating reparative-regenerative processes) was studied by enzyme-linked immunosorbent assay of conditioned media collected after 48 h cell incubation in minimal culture media. Results. The combined method ensured a stable cell yield with high reproducibility. Significant inter-donor variability in primary cell yield was noted. Isolated cells fulfilled the ISCT minimal criteria, exhibiting typical fibroblast-like morphology, characteristic immunophenotype, differentiation potential, and a high proportion of CFU, indicating the preservation of primitive progenitors. Proliferative analysis showed that PDT values remained comparable and did not change significantly between passages 1 and 3. Conditioned media from WJ-MSCs contained wide range of growth factors and cytokines, with inter-donor variability: VEGF, EGF, PDGF-BB, SCF, TNF-α, and TGF-β exhibited wide fluctuations, whereas NGF-β and FGF-β were relatively stable. Overall, WJ-MSC CM were characterized by very high levels of VEGF and EGF, high PDGF-BB, elevated TNF-α and TGF-β, and the lowest levels of FGF-β. Conclusions. The combined explant-enzymatic method is an efficient and standardized protocol for human WJ-MSC isolation, preserving high functional potency of cells for clinical and biobanking purposes.
- Open Access
- 17 February 2025
- Published by MDPI AG in Engineering Proceedings
- Vol. 81 (1) , 8
Bioengineering of Mesenchymal-Stromal-Cell-Based 3D Constructs with Different Cell Organizations
Standard 2D cultures inadequately mimic the natural microenvironment of mesenchymal stromal cells (MSCs), compromising their properties. This study investigated the impact of 3D cultures in spheroids, alginate microspheres (AMSs), and blood plasma scaffolds on human-adipose-derived MSC behavior. The cell morphology, viability/apoptosis (6-CFDA/Annexin-Cy3.18), actin filament development (phalloidin-FITC), and metabolic activity (Alamar Blue) were assessed on the 3rd day of the generated 3D construct cultures. The abilities for adipogenic and osteogenic differentiation were evaluated after 21 days of culture in media with inducers by Nile Red and Alizarin Red staining, respectively. The 3D culture supported closer-to-physiological cell interactions and morphology and resulted in F-actin reduction compared with the 2D culture. While the metabolic activity was elevated in the scaffolds, it was significantly reduced in the spheroids and AMSs, which reflected natural-like quiescence. The differentiation was maintained across all the 3D constructs. These findings highlight the essential influence of 3D construct design on MSC function, underscoring its potential for advancing both in vitro models and cell-based therapies.
- 17 February 2025
- Published by MDPI AG in Engineering Proceedings
- Vol. 81 (1) , 8
Open AccessBioengineering of Mesenchymal-Stromal-Cell-Based 3D Constructs with Different Cell Organizations
Standard 2D cultures inadequately mimic the natural microenvironment of mesenchymal stromal cells (MSCs), compromising their properties. This study investigated the impact of 3D cultures in spheroids, alginate microspheres (AMSs), and blood plasma scaffolds on human-adipose-derived MSC behavior. The cell morphology, viability/apoptosis (6-CFDA/Annexin-Cy3.18), actin filament development (phalloidin-FITC), and metabolic activity (Alamar Blue) were assessed on the 3rd day of the generated 3D construct cultures. The abilities for adipogenic and osteogenic differentiation were evaluated after 21 days of culture in media with inducers by Nile Red and Alizarin Red staining, respectively. The 3D culture supported closer-to-physiological cell interactions and morphology and resulted in F-actin reduction compared with the 2D culture. While the metabolic activity was elevated in the scaffolds, it was significantly reduced in the spheroids and AMSs, which reflected natural-like quiescence. The differentiation was maintained across all the 3D constructs. These findings highlight the essential influence of 3D construct design on MSC function, underscoring its potential for advancing both in vitro models and cell-based therapies.